Skip to Content

News List

Dr. Bucshon Applauds Modernizing Career and Technical Education Law

| Posted in Press Releases

(Washington, D.C.) – Congressman Larry Bucshon, M.D. (IN-08) released the following statement after President Trump signed into law the Strengthening Career and Technical Education for the 21st Century Act (H.R. 2353): “America has a booming economy and we now have a job market where the number of job openings exceeds the…

Dr. Bucshon Votes to Give Americans More Affordable Health Choices

| Posted in Press Releases

(Washington, D.C.) – Congressman Larry Bucshon, M.D. (IN-08) released the following statement after voting for the Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018 (H.R. 6311) and the Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018 (H.R. 6199):…

Dr. Bucshon Adamantly Supports Complete Repeal of the Medical Device Tax

| Posted in Press Releases

(Washington, D.C.) – Congressman Larry Bucshon, M.D. (IN-08) released the following statement in support of the Protect Medical Innovation Act, (H.R. 184) to repeal the medical device tax: “As a physician, I understand the vital importance the medical device industry plays in healthcare, and I routinely used innovative…

Dr. Bucshon Votes to Unleash Full Potential of Main Street

| Posted in Press Releases

(Washington, D.C.) – Congressman Larry Bucshon, M.D. (IN-08) released the following statement after voting in support of the Jobs and Investor Confidence Act of 2018 (S. 488): “Entrepreneurs and small businesses are the backbone of the American economy. Ensuring Hoosier small businesses have access to capital to get up and running,…

Dr. Bucshon Advocates Increased Transparency of 340B Drug Program

| Posted in Press Releases

(Washington, D.C.) – During today’s House Energy and Commerce Committee subcommittee hearing, Congressman Larry Bucshon, M.D. (IN-08) questioned witnesses on the need for improved transparency and greater oversight of the 340B drug program: “The 340B drug pricing program is an important tool that helps hospitals and other covered entities meet the healthcare…